Thomson Medical Group Limited (SGX:A50)
Singapore · Delayed Price · Currency is SGD 0.0610
0.00 (0.00%)
At close: Sep 29, 2025
Thomson Medical Group Income Statement
Financials in millions SGD. Fiscal year is July - June.
Millions SGD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
Operating Revenue | 394.66 | 351.15 | 355.77 | 333.71 | 240.4 | Upgrade |
Other Revenue | 60.87 | 31.5 | 4.79 | 4.79 | - | Upgrade |
| 455.53 | 382.65 | 360.56 | 338.5 | 240.4 | Upgrade | |
Revenue Growth (YoY) | 19.04% | 6.13% | 6.52% | 40.81% | 11.23% | Upgrade |
Cost of Revenue | 234.82 | 197.52 | 177.35 | 163.24 | 124.38 | Upgrade |
Gross Profit | 220.71 | 185.14 | 183.21 | 175.26 | 116.02 | Upgrade |
Other Operating Expenses | 166.12 | 83.24 | 79.88 | 65.52 | 49.25 | Upgrade |
Operating Expenses | 204.8 | 111.61 | 100.95 | 83.45 | 67.2 | Upgrade |
Operating Income | 15.91 | 73.52 | 82.26 | 91.81 | 48.81 | Upgrade |
Interest Expense | -59.66 | -51.55 | -30.51 | -23.5 | -23.61 | Upgrade |
Interest & Investment Income | 3.62 | 7.38 | 3.95 | 0.99 | 0.98 | Upgrade |
Earnings From Equity Investments | -0.48 | -0.19 | -0.49 | - | - | Upgrade |
EBT Excluding Unusual Items | -40.62 | 29.16 | 55.2 | 69.3 | 26.18 | Upgrade |
Pretax Income | -40.62 | 29.16 | 55.2 | 69.3 | 26.18 | Upgrade |
Income Tax Expense | 6.36 | 10.94 | 14.15 | 10.71 | 9.27 | Upgrade |
Earnings From Continuing Operations | -46.98 | 18.21 | 41.06 | 58.59 | 16.91 | Upgrade |
Net Income to Company | -46.98 | 18.21 | 41.06 | 58.59 | 16.91 | Upgrade |
Minority Interest in Earnings | -0.6 | -4.06 | -4.5 | -4.82 | -2.67 | Upgrade |
Net Income | -47.58 | 14.16 | 36.56 | 53.76 | 14.24 | Upgrade |
Net Income to Common | -47.58 | 14.16 | 36.56 | 53.76 | 14.24 | Upgrade |
Net Income Growth | - | -61.27% | -32.01% | 277.62% | - | Upgrade |
Shares Outstanding (Basic) | 26,441 | 26,441 | 26,441 | 26,441 | 26,441 | Upgrade |
Shares Outstanding (Diluted) | 26,459 | 26,459 | 26,447 | 26,441 | 26,441 | Upgrade |
Shares Change (YoY) | - | 0.05% | 0.02% | - | - | Upgrade |
EPS (Basic) | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade |
EPS (Diluted) | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade |
EPS Growth | - | -61.20% | -32.04% | 277.14% | - | Upgrade |
Free Cash Flow | 37.87 | 56.49 | 77.39 | 65.05 | 23.96 | Upgrade |
Free Cash Flow Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade |
Dividend Per Share | - | - | 0.000 | - | - | Upgrade |
Gross Margin | 48.45% | 48.38% | 50.81% | 51.78% | 48.26% | Upgrade |
Operating Margin | 3.49% | 19.21% | 22.81% | 27.12% | 20.30% | Upgrade |
Profit Margin | -10.44% | 3.70% | 10.14% | 15.88% | 5.92% | Upgrade |
Free Cash Flow Margin | 8.31% | 14.76% | 21.46% | 19.22% | 9.97% | Upgrade |
EBITDA | 41.73 | 94.14 | 95.42 | 102.95 | 59.54 | Upgrade |
EBITDA Margin | 9.16% | 24.60% | 26.46% | 30.41% | 24.77% | Upgrade |
D&A For EBITDA | 25.82 | 20.61 | 13.16 | 11.14 | 10.73 | Upgrade |
EBIT | 15.91 | 73.52 | 82.26 | 91.81 | 48.81 | Upgrade |
EBIT Margin | 3.49% | 19.21% | 22.81% | 27.12% | 20.30% | Upgrade |
Effective Tax Rate | - | 37.53% | 25.63% | 15.46% | 35.41% | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.